As life slips by: Why eye movement doesn't blur the picture
Two specific proteins bind during development to stabilize the brain cells that allow us to see things clearly, even as we move
2015-05-07
(Press-News.org) Researchers at University of California, San Diego School of Medicine and Shiley Eye Institute have identified the molecular "glue" that builds the brain connections that keep visual images clear and still, even as objects or your eyes move. Using mouse models, the researchers demonstrate that image stabilization depends upon two proteins, Contactin-4 and amyloid precursor protein, binding during embryonic development. The study is published May 7 by Neuron.
"In the visual system, precise connections between your eyes and brain help you see specific things and make sure those images are clear and crisp," said senior author Andrew D. Huberman, PhD, assistant professor of neurosciences, neurobiology and ophthalmology. "Sensors in the eye also detect movement and connect to the brain in just the right way to tell your eyes to move in the right direction without blurring images, the way a camera does if you try to take a picture while moving. Until now, we didn't really understand how the eye and brain control that on a molecular level."
To determine exactly how your eyes and brain work together to keep things steady, Huberman, lead author Jessica Osterhout and team labeled specific sets of neurons in the brain that make specific connections -- a technique pioneered by Huberman's lab. This approach allows researchers to look at individual components of the visual network and eventually identify the exact genes those cells switch on during development, as they make the appropriate connections.
From this, the team found Contactin-4, an adhesion molecule. They determined that Conactin-4's expression is very specific to those cells in the eye involved in image stabilization. When the researchers mutated Contactin-4, the circuit didn't form properly and visual cells didn't talk to the brain correctly. On the other hand, when they added Contactin-4 to a cell that doesn't normally produce it, that one additional protein was all the cell needed make the circuits for a steady eye-brain connection.
Then the team went looking for proteins that bind Contactin-4. They uncovered amyloid precursor protein, which has been widely studied for its role in Alzheimer's disease, but is also known to be an important factor in normal brain development. If amyloid precursor protein isn't available, the researchers discovered, Contactin-4 can't control development of the visual circuitry.
Based upon these findings, Huberman and colleagues hypothesize that there are also very specific sets of genes that make sure the correct neurons make the correct connections in other aspects of neural circuitry, in addition to vision. And these genes are very likely important for accurate sensory perception and behavior.
Next, Huberman and his team plan to take a closer look at how these genes and precise neural connections go wrong in cognitive diseases. For example, since the Contactin-4 gene is located in a cluster of genes that have been implicated in some forms of autism, they want to know if aberrations in that particular gene might play a role in development of the disease.
"My lab is also interested in figuring out how to reconnect or regenerate circuits damaged by injury or disease," Huberman said.
INFORMATION:
Co-authors of this study include Benjamin K. Stafford, and Phong L. Nguyen, UC San Diego; Yoshihiro Yoshihara, RIKEN Brain Science Institute.
This research was funded, in part, by the National Institutes of Health (grant RO1EY022157), National Science Foundation (grant DGE-1144086), E. Matilda Ziegler Foundation for the Blind and Pew Charitable Trusts.
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-07
In a large prospective study published online in the European Journal of Clinical Nutrition*, researchers looked at the association between nut consumption and risk of colorectal cancer among 75,680 women in the Nurses' Health Study, with no previous history of cancer.
Women who consumed a one-ounce serving of nuts, including tree nuts (such as almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts), two or more times per week had a 13% lower risk of colorectal cancer (RR, 0.87; 95% CI, 0.72-1.05; P=0.06) compared to those ...
2015-05-07
On 9 May we celebrate Europe Day. On this 65th anniversary of the Schuman Declaration 85% of Flemish adolescents and 80% of the adults feel European. 62% of the respondents also feel actively involved in what happens in the European Union. That is the conclusion of a study by the KU Leuven Centre for Political Research.
"I consider myself an EU citizen" and "I am proud to be living in Europe". These are just some of the statements that Soetkin Verhaegen presented to almost 3600 fifteen-year-olds and their parents (of whom over 4300 participated). She found that a surprisingly ...
2015-05-07
LAWRENCE -- The cliché version of the American dream usually involves getting married, finding a good job, raising 2.5 kids and buying a home with a white picket fence.
But in recent times spiking prices can make home ownership impossible -- or falling prices can trap homeowners in so-called "upside-down" mortgages, where debt dwarfs the shrinking value of a house.
"To determine the right price of a house, people need to make long-term projections of many uncertain economic variables, such as interest rate," said Shu Wu, associate professor of economics at the ...
2015-05-07
ANN ARBOR -- Arginine, a common amino acid found naturally in foods, breaks down dental plaque, which could help millions of people avoid cavities and gum disease, researchers at the University of Michigan and Newcastle University have discovered.
Alexander Rickard, assistant professor of epidemiology at the U-M School of Public Health, and colleagues, discovered that in the lab L-arginine -- found in red meat, poultry, fish and dairy products, and is already used in dental products for tooth sensitivity--stopped the formation of dental plaque.
"This is important ...
2015-05-07
TORONTO, May 7, 2015 -- Highly priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients, cautions York University Professor Dr. Joel Lexchin in the School of Health Policy and Management.
"Patients and their doctors should demand that regulators require pharma companies to provide clear evidence of clinical effectiveness of the drugs, resulting from rigorous methodology," suggests Lexchin. "Drug agencies like the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) don't actually look at ...
2015-05-07
Compliance with post-treatment surveillance, income level and the travel distance for follow-up care had effects on survival in patients with head and neck squamous cell cancer (HNSCC), according to a report published online by JAMA Otolaryngology-Head & Neck Surgery.
Post-treatment surveillance is a key component for patients with HNSCC, a cancer with a five-year survival rate of only slightly above 50 percent. The National Comprehensive Cancer Network guidelines recommend follow-up should consist of visits at least every one to three months during the first year after ...
2015-05-07
The use of cholesterol-lowering statins when men initiated androgen deprivation therapy for prostate cancer was associated with longer time to progression of the disease, according to an article published online by JAMA Oncology.
The gene SLCO2B1 acts as a transporter that enables a variety of drugs and hormones to enter cells. For example, dehydroepiandrosterone sulfate (DHEAS) is a precursor of testosterone and uses SLCO2B1 to get into cells. Similarly, statins use SLCO2B1 to enter cells as well. Previous research has suggested an association between statin use and ...
2015-05-07
Crigler-Najjar syndrome is a rare autosomal recessive disorder caused by mutations in the UGT1A1 gene, which result in the toxic accumulation of bilirubin, a substance made by the liver in the body. Indeed, when the UDP-glucuronosyltransferase 1 isotype A1 (UGT1A1), the enzyme responsible for removing bilirubin, doesn't work, the substance accumulates, causing a severe and chronic jaundice, and becoming toxic for the brain and leading to lethality.
Gene therapy has allowed the restoration of an equivalent level of bilirubin to those found in healthy animals
Federico ...
2015-05-07
This news release is available in French. Metabolic complications of obesity and overweight, such as type 2 diabetes, are an important challenge to public health. Teams led by Nicolas Venteclef, Inserm Research Fellow (Cordeliers Research Centre, Inserm/Pierre and Marie Curie University Joint Research Unit 1138, Paris, France) and Irina Udalova (Kennedy Institute of Rheumatology, University of Oxford, UK) in collaboration with several teams, have succeeded in elucidating part of the mechanisms involved in the development of these metabolic complications associated with ...
2015-05-07
Obesity and depression -- not only lack of sleep -- are underlying causes for regular drowsiness, according to Penn State College of Medicine researchers. They say these findings could lead to more personalized sleep medicine for those with excessive daytime sleepiness (EDS).
As much as 30 percent of the general population experiences EDS -- daytime drowsiness or sleepiness occurring throughout the day that can include irresistible sleep attacks. Feeling overly tired during the day can reduce job productivity and increase errors and absenteeism and may lead to more serious ...
LAST 30 PRESS RELEASES:
[Press-News.org] As life slips by: Why eye movement doesn't blur the picture
Two specific proteins bind during development to stabilize the brain cells that allow us to see things clearly, even as we move